Xilis and MD Anderson Announce Strategic Collaboration to Advance Novel Technology and Accelerate Therapeutic Development

&#13 Preclinical exploration settlement delivers collectively Xilis' MicroOrganoSphere™ platform with MD Anderson's know-how in most cancers research and therapeutic progress&#13 &#13 HOUSTON...